ADMA Biologics, Inc. (ADMA)
Largest Insider Buys in Sector
ADMA Stock Price History Chart
ADMA Stock Performance
About ADMA Biologics, Inc.
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Insider Activity of ADMA Biologics, Inc.
Over the last 12 months, insiders at ADMA Biologics, Inc. have bought $579,644 and sold $20.88M worth of ADMA Biologics, Inc. stock.
On average, over the past 5 years, insiders at ADMA Biologics, Inc. have bought $3.8M and sold $12.56M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Grossman Jerrold B (director) — $482,144. KWON YOUNG (director) — $97,500.
The last purchase of 130,000 shares for transaction amount of $482,144 was made by Grossman Jerrold B (director) on 2023‑08‑30.
List of Insider Buy and Sell Transactions, ADMA Biologics, Inc.
| 2024-06-14 | Sale | Grossman Adam S | President,CEO, and Interim CFO | 100,000 0.044% | $10.72 | $1.07M | +2.12% | |
| 2024-03-19 | Sale | ELMS STEVE | director | 411,829 0.1772% | $6.08 | $2.5M | +11.47% | |
| 2024-03-18 | Sale | ELMS STEVE | director | 49,887 0.0221% | $6.01 | $299,821 | +15.82% | |
| 2024-03-15 | Sale | ELMS STEVE | director | 183,008 0.0805% | $6.01 | $1.1M | +14.52% | |
| 2024-03-14 | Sale | ELMS STEVE | director | 448,276 0.1906% | $6.05 | $2.71M | +13.46% | |
| 2024-03-13 | Sale | ELMS STEVE | director | 407,000 0.1776% | $6.21 | $2.53M | +8.63% | |
| 2023-08-30 | Grossman Jerrold B | director | 130,000 0.0588% | $3.71 | $482,144 | +41.26% | ||
| 2023-08-24 | KWON YOUNG | director | 25,000 0.0108% | $3.90 | $97,500 | +33.07% | ||
| 2023-08-22 | Sale | Fong Bryant | director | 1.43M 0.637% | $3.87 | $5.54M | +31.27% | |
| 2023-08-18 | Sale | Grossman Adam S | President and CEO | 250,000 0.1139% | $4.15 | $1.04M | +23.66% | |
| 2023-08-16 | Sale | Grossman Adam S | President and CEO | 3 <0.0001% | $4.38 | $13 | +13.63% | |
| 2023-08-16 | Sale | LENZ BRIAN | EVP, CFO | 178,184 0.0804% | $4.45 | $793,400 | +13.63% | |
| 2023-08-15 | Sale | Grossman Adam S | President and CEO | 510,469 0.2298% | $4.54 | $2.32M | +11.01% | |
| 2023-08-15 | Sale | LENZ BRIAN | EVP, CFO | 211,578 0.0964% | $4.60 | $972,730 | +11.01% | |
| 2022-12-09 | Grossman Adam S | President and CEO | 29,965 0.0119% | $2.86 | $85,700 | +2.25% | ||
| 2022-12-09 | LENZ BRIAN | EVP, CFO | 6,993 0.0028% | $2.86 | $20,000 | +2.25% | ||
| 2021-10-25 | Grossman Adam S | President and CEO | 350,000 0.2039% | $1.00 | $350,000 | +57.32% | ||
| 2021-10-25 | LENZ BRIAN | EVP, CFO | 30,000 0.0175% | $1.00 | $30,000 | +57.32% | ||
| 2021-10-25 | Grossman Jerrold B | director | 100,000 0.0582% | $1.00 | $100,000 | +57.32% | ||
| 2021-10-25 | KWON YOUNG | director | 100,000 0.0582% | $1.00 | $100,000 | +57.32% |
Insider Historical Profitability
| ELMS STEVE | director | 2115671 1.1293% | $10.84 | 0 | 5 | |
| Grossman Adam S | President and CEO | 2081475 1.0059% | $10.84 | 37 | 4 | <0.0001% |
| LENZ BRIAN | EVP, CFO | 782013 0.3461% | $10.84 | 15 | 2 | +5.59% |
| Grossman Jerrold B | director | 443265 0.1962% | $10.84 | 17 | 0 | <0.0001% |
| KWON YOUNG | director | 277401 0.1228% | $10.84 | 2 | 0 | +57.32% |
| Fong Bryant | director | 0 0% | $10.84 | 0 | 1 | |
| PERCEPTIVE ADVISORS LLC | 10 percent owner | 13262375 5.8691% | $10.84 | 3 | 9 | <0.0001% |
| Biotest Divestiture Trust | 10 percent owner | 4295580 1.901% | $10.84 | 0 | 2 | |
| Aisling Capital II LP | 10 percent owner | 3620143 1.6021% | $10.84 | 1 | 0 | |
| Burrill Capital Fund IV, L.P. | 10 percent owner | 1433304 0.6343% | $10.84 | 1 | 0 | |
| Mond James | EVP, CSO and CMO | 73174 0.0324% | $10.84 | 8 | 0 | +2.86% |
| Guiheen Lawrence P. | director | 70000 0.031% | $10.84 | 5 | 0 | <0.0001% |
| RICHMAN ERIC I | director | 36530 0.0162% | $10.84 | 3 | 0 | +39.74% |
| DEMSKI MARTHA J | director | 4200 0.0019% | $10.84 | 2 | 0 | <0.0001% |
| Biotest AG | 10 percent owner | 0 0% | $10.84 | 1 | 1 | +103.33% |
Institutional Investor Ownership
| BlackRock | $120.12M | 7.85 | 18.2M | +1.57% | +$1.86M | <0.01 | |
| The Vanguard Group | $83.75M | 5.47 | 12.69M | -1.57% | -$1.34M | <0.01 | |
| State Street | $69.65M | 4.55 | 10.55M | +11.28% | +$7.06M | <0.01 | |
| Nuveen | $69.06M | 4.51 | 10.46M | -7.87% | -$5.9M | 0.02 | |
| Invesco | $51.51M | 3.37 | 7.8M | +27.69% | +$11.17M | 0.01 | |
| American Century Investments | $47.05M | 3.08 | 7.13M | +4.64% | +$2.08M | 0.03 | |
| Perceptive Advisors | $42.46M | 2.78 | 6.43M | 0% | +$0 | 0.03 | |
| Awm Investment Company Inc | $37.72M | 2.47 | 5.71M | -4.75% | -$1.88M | 5.6 | |
| D. E. Shaw & Co. | $35.52M | 2.32 | 5.38M | -17.38% | -$7.47M | 0.05 | |
| Geode Capital Management | $31.72M | 2.07 | 4.81M | +3.4% | +$1.04M | <0.01 | |
| Magnetar Capital | $30.75M | 2.01 | 4.66M | -25.84% | -$10.71M | 0.86 | |
| Two Sigma | $25.38M | 1.66 | 3.85M | +23.86% | +$4.89M | 0.04 | |
| Morgan Stanley | $25.19M | 1.65 | 3.82M | +0.86% | +$214,770.60 | <0.01 | |
| Dimensional Fund Advisors | $23.75M | 1.55 | 3.6M | +3.06% | +$706,034.98 | 0.01 | |
| Two Sigma Advisers LP | $22.83M | 1.49 | 3.46M | +24.55% | +$4.5M | 0.04 | |
| Ophir Asset Management | $22.63M | 1.48 | 3.43M | New | +$22.63M | 3.97 | |
| Stonepine Capital Management Llc | $22.62M | 1.48 | 3.43M | -62.84% | -$38.25M | 18.26 | |
| Assenagon Asset Management S.A. | $22.09M | 1.44 | 3.35M | -15.18% | -$3.95M | 0.06 | |
| Deutsche Bank | $20.15M | 1.32 | 3.05M | -0.09% | -$18,955.20 | 0.01 | |
| Oberweis Asset Management Inc | $18.42M | 1.2 | 2.79M | +2.95% | +$528,000.00 | 1.33 | |
| Mesirow Institutional Investment Management Inc | $17.22M | 1.13 | 2.61M | New | +$17.22M | 1.53 | |
| Driehaus Capital Management LLC | $17.03M | 1.11 | 2.58M | -21.16% | -$4.57M | 0.17 | |
| Northern Trust | $13.94M | 0.91 | 2.11M | -3.88% | -$563,448.61 | <0.01 | |
| Renaissance Technologies | $13.25M | 0.87 | 2.01M | +89.71% | +$6.26M | 0.02 | |
| Charles Schwab | $11.72M | 0.77 | 1.78M | +8.46% | +$913,552.20 | <0.01 | |
| Millennium Management LLC | $11.29M | 0.74 | 1.71M | -50.46% | -$11.5M | 0.01 | |
| Federated Hermes | $11.26M | 0.74 | 1.71M | +111.41% | +$5.93M | 0.03 | |
| Voloridge Investment Management, LLC | $11.08M | 0.72 | 1.68M | New | +$11.08M | 0.03 | |
| Altium Capital Management Lp | $10.16M | 0.66 | 1.54M | +40.64% | +$2.94M | 4.72 | |
| Velan Capital | $10.09M | 0.66 | 1.53M | -28.44% | -$4.01M | 5.49 | |
| Rice Hall James & Associates, LLC | $7.96M | 0.52 | 1.21M | New | +$7.96M | 0.48 | |
| Russell Investments Group Ltd | $7.72M | 0.5 | 1.17M | +90.72% | +$3.67M | 0.01 | |
| Cubist Systematic Strategies | $6.81M | 0.45 | 1.03M | +346.65% | +$5.28M | 0.06 | |
| Goldman Sachs | $5.97M | 0.39 | 904,072 | -47.81% | -$5.47M | <0.01 | |
| CastleArk Management, LLC | $5.4M | 0.35 | 818,110 | New | +$5.4M | 0.23 | |
| AQR Capital | $5.39M | 0.35 | 816,953 | +38.19% | +$1.49M | 0.01 | |
| PEREGRINE CAPITAL MANAGEMENT INC | $5.38M | 0.35 | 815,044 | -7.69% | -$448,397.37 | 0.16 | |
| Boothbay Fund Management LLC | $5.19M | 0.34 | 786,807 | -27.8% | -$2M | 0.17 | |
| Eam Investors | $5.09M | 0.33 | 771,563 | New | +$5.09M | 1.18 | |
| BNY Mellon | $4.73M | 0.31 | 716,913 | -8.08% | -$415,727.42 | <0.01 | |
| Rafferty Asset Management Llc | $4.5M | 0.29 | 682,265 | +25.34% | +$910,245.60 | 0.01 | |
| Citigroup | $4.18M | 0.27 | 632,759 | +139.69% | +$2.43M | <0.01 | |
| Hillsdale Investment Management Inc. | $4.16M | 0.27 | 629,900 | +41,893.33% | +$4.15M | 0.34 | |
| Eam Investors | $4.11M | 0.27 | 622,086 | New | +$4.11M | 0.64 | |
| Wellington Management Company | $4.04M | 0.26 | 612,758 | +186.36% | +$2.63M | <0.01 | |
| ClariVest Asset Management LLC | $3.76M | 0.25 | 569,225 | +186.18% | +$2.44M | 0.39 | |
| UBS | $3.73M | 0.24 | 565,431 | +13.47% | +$443,071.25 | <0.01 | |
| Calamos Advisors LLC | $3.67M | 0.24 | 556,598 | +122.47% | +$2.02M | 0.03 | |
| Bank of America | $3.56M | 0.23 | 539,421 | -61.35% | -$5.65M | <0.0001 | |
| State of Wisconsin Investment Board | $3.22M | 0.21 | 487,776 | +204.74% | +$2.16M | 0.01 |